{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:08:50Z","timestamp":1792415330146,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cca.2023.117332","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T20:48:27Z","timestamp":1680814107000},"page":"117332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Factors affecting the evaluation and use of a hemoglobin A2 method \u2013 Lot-to-lot variation, long-term deviation and carry-over"],"prefix":"10.1016","volume":"544","author":[{"given":"Britta","family":"Landin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Sisowath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Str\u00e5lfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117332_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-553X.2011.01368.x","article-title":"ICSH recommendations for the measurement of Haemoglobin A2","volume":"34","author":"Stephens","year":"2012","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.cca.2023.117332_b0010","doi-asserted-by":"crossref","unstructured":"J. Traeger-Synodinos, C.L. Harteveld, J. M. Old, J., M. Petrou, R. Galanello, P. Giordano, P., M. Angastioniotis, B. De la Salle, S. Henderson, A. May, EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies, Eur. J. Hum. Genet. 23 (2015) 426-437.","DOI":"10.1038\/ejhg.2014.131"},{"key":"10.1016\/j.cca.2023.117332_b0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2020.11.008","article-title":"A roadmap for the standardization of hemoglobin A2","volume":"512","author":"Mosca","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1515\/cclm-2012-0575","article-title":"Analytical goals for the determination of Hb A2","volume":"51","author":"Mosca","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2023.117332_b0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ijlh.12966","article-title":"Evaluation of the suitability of the World Health Organization International Reference Reagent for Hb A2 quantitation (89\/666) for continued use","volume":"41","author":"De la Salle","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.cca.2023.117332_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ijlh.13403","article-title":"Further evaluation of the world health organization international reference reagent for Haemoglobin A2 measurement","volume":"43","author":"Wild","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.cca.2023.117332_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2018.10.024","article-title":"Determination of Hb A2 by quantitative bottom-up proteomics and isotope dilution mass spectrometry","volume":"487","author":"Arsene","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1515\/cclm-2017-0454","article-title":"Irregular analytical errors in diagnostic testing - a novel concept","volume":"56","author":"Vogeser","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2023.117332_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2016.05.023","article-title":"Developing a reference system for the IFCC standardization of Hb A2","volume":"467","author":"Paleari","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2017.12.001","article-title":"Calibration by commutable control materials is able to reduce inter-method differences of current high-performance methods for Hb A2","volume":"477","author":"Paleari","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cca.2012.03.027","article-title":"Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies","volume":"413","author":"Greene","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jcp.2008.056945","article-title":"The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies","volume":"62","author":"Mosca","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2023.117332_b0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.clinbiochem.2015.04.001","article-title":"Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and Hb A2","volume":"48","author":"Rodriguez-Capote","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2023.117332_b0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2018.11.007","article-title":"Reference intervals for Hb A and HbF and cut-off value of HbA2 for \u03b2-thalassemia carrier screening in a Guizhou population of reproductive age","volume":"65","author":"Han","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2023.117332_b0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1515\/cclm-2022-0083","article-title":"An approach for determining allowable between reagent lot variation","volume":"60","author":"van Schrojenstein Lantman","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2023.117332_b0080","first-page":"51","article-title":"Lot-to-lot variation","volume":"39","author":"Thompson","year":"2018","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.cca.2023.117332_b0085","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1373\/clinchem.2013.205070","article-title":"Failure of current laboratory protocols to detect lot-lot reagent differences: Findings and possible solutions","volume":"59","author":"Algeciras-Schimnich","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2023.117332_b0090","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1373\/clinchem.2015.242511","article-title":"Detecting long-term drift in reagent lots","volume":"61","author":"Liu","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2023.117332_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2022.07.006","article-title":"Lot-to-lot reagent verification: Effetc of sample size and replicate measurement on linear regression approaches","volume":"534","author":"Koh","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117332_b0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1515\/cclm-2022-0092","article-title":"Lot-to-lot reagent verification: challenges and possible solutions","volume":"60","author":"Loh","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2023.117332_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1515\/cclm-2021-1262","article-title":"A national surveillence program for evaluating new reagent lots in medical laboratories","volume":"60","author":"Solsvik","year":"2022","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:04:42Z","timestamp":1762113882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"alternative-id":["S0009898123001341"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117332","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors affecting the evaluation and use of a hemoglobin A2 method \u2013 Lot-to-lot variation, long-term deviation and carry-over","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117332"}}